Research suggests that GLP-1 medications, such as semaglutide and Ozempic, may have a positive effect on mental health, potentially reducing the risk of depression, anxiety, and addiction. The findings imply that these medications could have benefits beyond their intended use for weight loss, although the extent of these benefits and potential risks are still being explored. The exact nature and scope of the mental health effects of GLP-1 medications are not yet fully clear, with studies and scientists indicating a range of possible outcomes.